- Filed
- Oct 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Sep 29, 2025 | 206.28M sh |
| Shares Diluted | Q3 2025 · Aug 31, 2025 | 222.72M sh |
| Shares Diluted | Q3 2025 · Aug 31, 2025 | 222.54M sh |
| Shares Diluted | Q3 2025 · Aug 31, 2024 | 221.7M sh |
| Shares Diluted | Q3 2025 · Aug 31, 2024 | 224.18M sh |
| Stock Repurchased | Q3 2025 · Aug 31, 2025 | $58.49M |
| Stock Repurchased | Q3 2025 · Aug 31, 2024 | $44.31M |
| Dividends Paid | Q3 2025 · Aug 31, 2025 | $280.59M |
| Dividends Paid | Q3 2025 · Aug 31, 2024 | $221.39M |
| Capex | Q3 2025 · Aug 31, 2025 | $151.43M |
| Capex | Q3 2025 · Aug 31, 2024 | $180.65M |
| Short Term Debt | Q3 2025 · Aug 31, 2025 | $1.23B |
| Short Term Debt | Q3 2025 · Nov 30, 2024 | $443.16M |
| Cash And Equivalents | Q3 2025 · Aug 31, 2025 | $11.46B |
| Cash And Equivalents | Q3 2025 · Nov 30, 2024 | $12.15B |
| Stockholders Equity | Q3 2025 · Aug 31, 2025 | $10.44B |
| Stockholders Equity | Q3 2025 · Nov 30, 2024 | $10.16B |
| Total Liabilities | Q3 2025 · Aug 31, 2025 | $58.82B |
| Total Liabilities | Q3 2025 · Nov 30, 2024 | $54.13B |
| Total Assets | Q3 2025 · Aug 31, 2025 | $69.32B |
| Total Assets | Q3 2025 · Nov 30, 2024 | $64.36B |
| Eps Diluted | Q3 2025 · Aug 31, 2025 | $1.01 |
| Eps Diluted | Q3 2025 · Aug 31, 2025 | $1.98 |
| Eps Diluted | Q3 2025 · Aug 31, 2024 | $0.75 |
| Eps Diluted | Q3 2025 · Aug 31, 2024 | $2.06 |
| Eps Basic | Q3 2025 · Aug 31, 2025 | $1.04 |
| Eps Basic | Q3 2025 · Aug 31, 2025 | $2.05 |
| Eps Basic | Q3 2025 · Aug 31, 2024 | $0.78 |
| Eps Basic | Q3 2025 · Aug 31, 2024 | $2.12 |
| Cost Of Revenue | Q3 2025 · Aug 31, 2025 | $34.43M |
| Cost Of Revenue | Q3 2025 · Aug 31, 2025 | $118.96M |
| Cost Of Revenue | Q3 2025 · Aug 31, 2024 | $37.4M |
| Cost Of Revenue | Q3 2025 · Aug 31, 2024 | $109.53M |
| Revenue | Q3 2025 · Aug 31, 2025 | $1.5B |
| Revenue | Q3 2025 · Aug 31, 2025 | $3.88B |
| Revenue restated | Q3 2025 · Aug 31, 2024 | $1.28B |
| Revenue restated | Q3 2025 · Aug 31, 2024 | $3.41B |